Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-108451
Filing Date
2024-10-15
Accepted
2024-10-15 10:41:13
Documents
1
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2426154-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2426154-1_3seq1.xml 3 8519
  Complete submission text file 0001104659-24-108451.txt   10137
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Issuer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address
Duxbury Joseph (Reporting) CIK: 0002040767 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56225 | Film No.: 241370103